| Application no. and date | 18732041.1 (espacenet) (Federated) (European Patent Register), 20180614 | | Patent/reg. no. and date | DK/EP 3638373, 20240904 | | Publication date | 20200422 | | Priority no. and date | GB 201709444, 20170614, GB 201709440, 20170614, GB 201710495, 20170630, GB 201710494, 20170630, GB 201720543, 20171208, GB 201720542, 20171208, GB 201802679, 20180220, GB 201808473, 20180523 | | EP pub. no. and date |
EP 3638373 20200422 | | Effective date | | | Applicant/owner | Medimmune Limited, Milstein Building Granta Park
Cambridge, Cambridgeshire CB21 6GH, GB,
ADC Therapeutics SA, route de la Corniche 3B
1066 Epalinges, CH | | Applicant ref. no. | | | Inventor | FEINGOLD, Jay Marshall, c/o ADC Therapeutics Americas
430 Mountain Ave. 4th Floor
Murray Hill
New Jersey 07974, US,
UNGAR, David Rodney, c/o ADC Therapeutics Americas
430 Mountain Ave. 4th Floor
Murray Hill
New Jersey 07974, US | | Representative | | | Opponent | | | IPC Class | A61K 31/5517 (2006.01) , A61K 47/68 (2017.01) , A61P 35/00 (2006.01) , A61P 39/00 (2006.01) , C07K 16/28 (2006.01) | | Title | DOSAGE REGIMES FOR THE ADMINISTRATION OF AN ANTI-CD19 ADC | | Int. application no. | EP2018065873 | | Int. publication no. | WO2018229222 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
